A la une
Europe – Joint strategy sets direction of EMA and EU medicines...
EMA and the Heads of Medicines Agencies (HMA) have published their joint EU medicines agencies’ network strategy to 2028 (EMANS), following its recent adoption by the HMA...
Europe – EMA qualifies first artificial intelligence tool to diagnose inflammatory...
EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial intelligence (AI). The tool,...
Europe – MDCG 2022-3 rev.1 – Verification of manufactured class D...
Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) establishes
the requirements for notified bodies involved in the conformity assessment of applicable classes of...
France – Cannabis thérapeutique : le gouvernement avance vers une généralisation...
L’autorisation de traitements à base de cannabis en France, sur laquelle régnait un grand flou depuis plus d’un an, vient de franchir un pas...
